Home LiteratureArticle Details
PMID: 13513912 Published · ppublish English Journal Article

Studies on the activation of a proesterase associated with partially purified first component of human complement.

The Journal of experimental medicine ·Vol. 107 ·No. 3 ·1958-03-01 ·Pages 451-74

LEPOW IH, RATNOFF OD, LEVY LR

Abstract

It has been found that under a wide range of physico-chemical conditions a positive correlation exists between the rate of disappearance of hemolytically active, partially purified first component of human complement and the rate of activation of an esterase hydrolyzing N-acetyl-L-tyrosine ethyl ester. Both reactions follow the kinetic equation for second order autocatalysis, with an apparent energy of activation of 31,000 calories per mol. They occur optimally at pH 7.3-7.7 and are inhibited by ionic strengths greater than 0.15, by 5 x 10(5)M ethylenediaminetetraacetic acid, and by a heat-labile serum inhibitor which appears unrelated to any component of complement. The activation of first component to esterase resembles closely the activation of trypsinogen to trypsin. Partially purified first component, containing plasminogen, may also be activated to esterase by addition of streptokinase. The significance of these data with respect to the postulated existence of first component as a proesterase and its possible role in complement-"fixation" is discussed.

Keywords
COMPLEMENT ESTERASES
MeSH Terms
Complement System Proteins Esterases Humans Kinetics Trypsin Tyrosine
Chemicals
Tyrosine ethyl N-alpha-acetyl-tyrosinate Complement System Proteins Esterases Trypsin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
LEPOW I H
RATNOFF O D
LEVY L R
References (12)
12 references, click to expand
  1. A COMPARISON OF HUMAN AND GUINEA PIG COMPLEMENTS AND THEIR COMPONENT FRACTIONS.
    J Exp Med. 1945 May 1;81(5):449-68 PMID: 19871469
  2. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
    Science. 1954 Aug 20;120(3112):279-85 PMID: 13186838
  3. The influence of calcium ions on the inactivation of human complement and its components by plasmin.
    J Exp Med. 1953 Sep;98(3):277-89 PMID: 13084846
  4. Inhibition of immune hemolysis by diisopropyl fluorophosphate.
    Biochim Biophys Acta. 1955 Oct;18(2):283-4 PMID: 13276376
  5. Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate.
    J Immunol. 1956 Dec;77(6):462-8 PMID: 13398627
  6. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.
    J Immunol. 1954 Sep;73(3):146-58 PMID: 13201755
  7. Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.
    Proc Soc Exp Biol Med. 1952 Apr;79(4):692-4 PMID: 14920537
  8. Some properties of an esterase derived from preparations of the first component of complement.
    J Exp Med. 1957 Aug 1;106(2):327-43 PMID: 13449241
  9. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.
    J Clin Invest. 1955 Apr;34(4):602-13 PMID: 14367514
  10. The action of plasmin on synthetic substrates.
    J Biol Chem. 1954 May;208(1):85-93 PMID: 13174517
  11. The inactivation of complement and its components by plasmin.
    J Exp Med. 1953 Apr;97(4):573-89 PMID: 13052820
  12. Elution of an esterase from antigen-antibody aggregates treated with human complement.
    Proc Soc Exp Biol Med. 1956 May;92(1):111-4 PMID: 13336090
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1958-03-01
Pages
451-74
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2136687
Subset
OM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]